The Food and Drug Administration this week issued guidance intended to clarify the agency’s expectations when electronic health records are used as a source of data in clinical investigations. The guidance applies to clinical investigations of human drugs and biological products, medical devices and combination products, including investigations conducted in clinical practice settings.

Related News Articles

Headline
The Centers for Medicare…
Headline
The AHA today shared with the Centers for Medicare…
Headline
Eligible hospitals and critical access hospitals that did not qualify as meaningful users of certified electronic health record technology for the 2019…
Headline
More than 9 in 10 hospitals used their electronic health record data to inform clinical practice in 2017.
Headline
Commenting Friday on the Office of the National Coordinator’s draft strategy to reduce regulatory and administrative burden related to health information…
Headline
The Government Accountability Office today released a congressionally-mandated report examining approaches and challenges to matching patients to their…